Completed NA INTERVENTIONAL 1-arm NCT00881309

To Compare the Efficacy and Safety of Tripterygium (TW) Versus AZA in the Maintenance Therapy for Lupus Nephritis

To Compare the Efficacy and Safety of Tripterygium (TW) vs Aza in the Maintenance Therapy for Lupus Nephritis

Sponsor: Nanjing University School of Medicine

Updated 5 times since 2017 Last updated: May 17, 2011 Started: Mar 31, 2009 Primary completion: Apr 30, 2011 Completion: May 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00881309, this NA trial focuses on Lupus Nephritis and remains completed. Sponsored by Nanjing University School of Medicine, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nanjing University School of Medicine

Data source: Nanjing University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China